Every time a cell copies its DNA, parts of the genome are exposed and vulnerable to damage or errors. Molecular biologist Simon Boulton is interested in how cells spot and repair damage to their DNA, ...

Acrivon Therapeutics trades below cash value, with the market deeply discounting its platform and pipeline despite promising ...

Although about 90 per cent of cancers are sporadic and can affect anyone regardless of genetics, experts say small, sustained ...

Arctic's bowhead whales defy ageing norms, living over two centuries with remarkable disease resistance. A groundbreaking ...

Researchers at the University of Liverpool have discovered that SYCP1, a protein previously thought to function only during ...

Modern medicine has made significant advances in cancer treatments over the decades. But all cancer therapies still face one ...

A highly sensitive blood test can detect signs of pancreatic cancer that standard methods often miss, according to results of ...

Patients with cancer who have germline mutations overwhelmingly acknowledge the importance of informing relatives of their risks, but gaps in testing show the health care system has not adequately ...

Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...

Blue Shield of California is blaming a phone system “routing” error after a San Francisco firefighter’s oncologist was unable to appeal the denial of his cancer ...

The epigenetic modifier MLL4 has an unassuming name—the 4, for instance, indicates it's just one in a family of such ...

Acquisition focused on clinical-stage program potravitug, a first-in-class BK polyomavirus monoclonal antibodyTotality of evidence from the Phase II SAFE KIDNEY II trial supports initiation of pivotal ...